title: A case of organizing pneumonia associated with rituximab.
abstract: Rituximab is a human/murine chimeric anti-CD20 monoclonal antibody used to treat CD20-positive B-cell non-Hodgkin's lymphoma (NHL). Although most of the adverse effects associated with rituximab are usually reversible and temporary infusion-related reactions, including fever, chills, flushing and skin reactions, there are several reports of pulmonary events after long-term administration of rituximab. We present a case of asymptomatic nodular organizing pneumonia occurring during rituximab-based chemotherapy in a patient with non-Hodgkin's lymphoma.
authors.affiliation: Department of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Korea.
authors.forename: Chi Hoon
authors.initials: CH
authors.lastname: Maeng
authors.forename: Sang Ouk
authors.initials: SO
authors.lastname: Chin
authors.forename: Byung Hyuk
authors.initials: BH
authors.lastname: Yang
authors.forename: Si-young
authors.initials: SY
authors.lastname: Kim
authors.forename: Hwi-Joong
authors.initials: HJ
authors.lastname: Youn
authors.forename: Kyung Sam
authors.initials: KS
authors.lastname: Cho
authors.forename: Sun Kyung
authors.initials: SK
authors.lastname: Baek
authors.forename: Sun
authors.initials: S
authors.lastname: Lee